• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药防治新冠肺炎研究进展。

Research progress of traditional Chinese medicine against COVID-19.

机构信息

National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China; Drug Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China.

National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.

出版信息

Biomed Pharmacother. 2021 May;137:111310. doi: 10.1016/j.biopha.2021.111310. Epub 2021 Feb 3.

DOI:10.1016/j.biopha.2021.111310
PMID:33761591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857050/
Abstract

BACKGROUND

Currently, the number of confirmed cases and deaths of COVID-19 worldwide continues to rise, receiving great concern from the international community. However, there is no specific and widely accepted effective vaccines. The experience in controlling the outbreak in China has proven the effectiveness of traditional Chinese medicine (TCM).

OBJECTIVES

This review aims to evaluate the role of TCM in COVID-19 treatment, hoping to provide references for prevention and control of global pandemic.

DATA SOURCES

China National Knowledge Infrastructure, Web of Science, Baidu Scholar, ScienceDirect, Elsevier and PubMed were used to search literatures published from December 2019 to December 2020 by entering the keywords "Traditional Chinese medicine", "COVID-19″, "Severe acute respiratory syndrome coronavirus 2″, "Pathogenesis", "Syndrome differentiation", "Prescriptions" and their combinations. Hence, we have performed an extensive review of research articles, reviews and primary scientific studies to identify TCM against COVID-19.

RESULTS

Among clinical treatments of COVID-19, several TCM prescriptions and characteristic therapies have been effectively suggested, the underlying mechanisms of which are mainly involved in antiviral, anti-inflammatory, immunomodulatory and organ-protective effects of multi-components acting on multi-targets at multi-pathways.

CONCLUSIONS

This review may provide meaningful and feasible information that can be considered for the treatment of COVID-19 pandemic globally.

摘要

背景

目前,全球新冠肺炎确诊病例和死亡人数持续上升,引起国际社会高度关注。然而,目前尚无特效药物和广泛认可的有效疫苗。中国在疫情防控中积累的经验证明了中医药的有效性。

目的

评价中医药在新冠肺炎治疗中的作用,为全球疫情防控提供参考。

资料来源

检索 2019 年 12 月至 2020 年 12 月期间在中国国家知识基础设施、Web of Science、百度学术、ScienceDirect、爱思唯尔和 PubMed 数据库中以“Traditional Chinese medicine”“COVID-19”“Severe acute respiratory syndrome coronavirus 2”“Pathogenesis”“Syndrome differentiation”“Prescriptions”为关键词,结合其他相关关键词组合,对中医药治疗新冠肺炎的相关文献进行检索。因此,我们对研究论文、综述和初步科学研究进行了广泛的回顾,以确定中医药防治新冠肺炎的作用。

结果

在新冠肺炎的临床治疗中,提出了几种有效的中药方剂和特色疗法,其作用机制主要涉及抗病毒、抗炎、免疫调节和多成分多靶点多途径的器官保护作用。

结论

本综述可为全球新冠肺炎大流行的治疗提供有意义且可行的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/ff532c923f44/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/e2fb7ade5844/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/67328335da73/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/a05eb11e302b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/ff1810353678/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/ff532c923f44/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/e2fb7ade5844/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/67328335da73/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/a05eb11e302b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/ff1810353678/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcd/7857050/ff532c923f44/gr4_lrg.jpg

相似文献

1
Research progress of traditional Chinese medicine against COVID-19.中医药防治新冠肺炎研究进展。
Biomed Pharmacother. 2021 May;137:111310. doi: 10.1016/j.biopha.2021.111310. Epub 2021 Feb 3.
2
Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice.中医药在抗击 COVID-19 中的补充疗法——基于循证研究和临床实践的综述。
J Adv Nurs. 2021 Apr;77(4):1635-1644. doi: 10.1111/jan.14673. Epub 2020 Nov 29.
3
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
4
Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.中药和系统药理学在新冠病毒防治药物中的应用。
Am J Chin Med. 2021;49(5):1045-1061. doi: 10.1142/S0192415X21500506.
5
[Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence].[中药防治疫病的用药规律及作用机制:基于中医寒疫理论]
Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(17):4765-4777. doi: 10.19540/j.cnki.cjcmm.20220528.501.
6
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.网络药理学与实验验证揭示麻杏石甘汤防治 2019 年冠状病毒病(COVID-19)的潜在作用。
J Ethnopharmacol. 2021 May 10;271:113854. doi: 10.1016/j.jep.2021.113854. Epub 2021 Jan 26.
7
Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.中医药防治新型冠状病毒肺炎的研究进展
Chin J Nat Med. 2020 Dec;18(12):881-889. doi: 10.1016/S1875-5364(20)60031-0.
8
Traditional Chinese Medicine as Potential Therapy for COVID-19.传统中医药治疗 COVID-19 的潜力。
Am J Chin Med. 2020;48(6):1263-1277. doi: 10.1142/S0192415X20500627. Epub 2020 Sep 9.
9
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
10
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.293 例新冠肺炎住院患者的临床特征及中医治疗特点。
Front Med. 2020 Dec;14(6):760-775. doi: 10.1007/s11684-020-0803-8. Epub 2020 Sep 14.

引用本文的文献

1
Plant growth-promoting rhizobacteria enhance active ingredient accumulation in medicinal plants at elevated CO and are associated with indigenous microbiome.植物促生根际细菌在高浓度二氧化碳条件下可促进药用植物中活性成分的积累,并与本地微生物群落有关。
Front Microbiol. 2024 Aug 26;15:1426893. doi: 10.3389/fmicb.2024.1426893. eCollection 2024.
2
Unlocking the Medicinal Potential of Plant-Derived Extracellular Vesicles: current Progress and Future Perspectives.植物源细胞外囊泡的药用潜力:当前进展与未来展望。
Int J Nanomedicine. 2024 May 27;19:4877-4892. doi: 10.2147/IJN.S463145. eCollection 2024.
3
Unraveling the Mechanism of Xiaochaihu Granules in Alleviating Yeast-Induced Fever Based on Network Analysis and Experimental Validation.

本文引用的文献

1
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.连花清瘟胶囊治疗新型冠状病毒肺炎有效性和安全性的多中心前瞻性随机对照临床试验
Phytomedicine. 2021 May;85:153242. doi: 10.1016/j.phymed.2020.153242. Epub 2020 May 16.
2
Effect and safety of Chinese herbal medicine granules in patients with severe coronavirus disease 2019 in Wuhan, China: a retrospective, single-center study with propensity score matching.中药颗粒剂对武汉重症 2019 冠状病毒病患者的疗效和安全性:一项回顾性、单中心、倾向评分匹配研究。
Phytomedicine. 2021 May;85:153404. doi: 10.1016/j.phymed.2020.153404. Epub 2020 Nov 5.
3
基于网络分析和实验验证揭示小柴胡颗粒缓解酵母致热的机制
Pharmaceuticals (Basel). 2024 Apr 8;17(4):475. doi: 10.3390/ph17040475.
4
Properties and Fungal Communities of Different Soils for Growth of the Medicinal Asian Water Plantain, , in Fujian, China.中国福建用于药用泽泻生长的不同土壤的性质及真菌群落
J Fungi (Basel). 2024 Feb 29;10(3):187. doi: 10.3390/jof10030187.
5
The History of Controlling and Treating Infectious Diseases in Ancient China.中国古代防治传染病的历史。
Curr Med Sci. 2024 Feb;44(1):64-70. doi: 10.1007/s11596-024-2831-0. Epub 2024 Feb 23.
6
Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis.绘制纳米技术与SARS-CoV-2/新冠肺炎的交叉领域:一项文献计量分析。
Infect Med (Beijing). 2022 Jun;1(2):103-112. doi: 10.1016/j.imj.2022.06.005. Epub 2022 Jun 26.
7
Systematically uncovering the absorbed effective substances of Radix Scutellaria-licorice drug pair in rat plasma against COVID-19 using a combined UHPLC-Q-TOF-MS analysis and target network pharmacology.采用 UHPLC-Q-TOF-MS 分析与靶标网络药理学相结合的方法系统挖掘黄芩-甘草药对防治 COVID-19 在大鼠血浆中的吸收有效物质
PLoS One. 2023 Aug 9;18(8):e0289121. doi: 10.1371/journal.pone.0289121. eCollection 2023.
8
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2.伞形花内酯和圣草酚可抑制新型冠状病毒2的细胞进入。
Cell Biosci. 2023 Jun 28;13(1):118. doi: 10.1186/s13578-023-01070-y.
9
Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs.解析连花清瘟胶囊对 COVID-19 的抑制作用及其主要植物药对的协同作用。
Chin J Nat Med. 2023 May;21(5):383-400. doi: 10.1016/S1875-5364(23)60455-8.
10
Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.化湿败毒颗粒治疗新型冠状病毒奥密克戎变异株感染患者的有效性和安全性:一项单中心回顾性队列研究。
Chin J Integr Med. 2024 Feb;30(2):107-114. doi: 10.1007/s11655-023-3549-8. Epub 2023 May 24.
Prospective role of thyroid disorders in monitoring COVID-19 pandemic.
甲状腺疾病在监测新冠疫情中的前瞻性作用。
Heliyon. 2020 Dec;6(12):e05712. doi: 10.1016/j.heliyon.2020.e05712. Epub 2020 Dec 13.
4
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.新型冠状病毒肺炎:康复或死亡的新兴免疫病理决定因素
Front Microbiol. 2020 Dec 1;11:588409. doi: 10.3389/fmicb.2020.588409. eCollection 2020.
5
Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.用于治疗新型冠状病毒肺炎和类风湿关节炎的中药方剂的相似性与特异性
ACS Omega. 2020 Nov 18;5(47):30519-30530. doi: 10.1021/acsomega.0c04377. eCollection 2020 Dec 1.
6
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial.中药与洛匹那韦利托那韦治疗成人 2019 冠状病毒病的疗效和安全性:一项非随机对照试验。
Phytomedicine. 2021 Jan;81:153367. doi: 10.1016/j.phymed.2020.153367. Epub 2020 Oct 8.
7
Treatment and prognosis of COVID-19: Current scenario and prospects (Review).2019冠状病毒病的治疗与预后:现状与展望(综述)
Exp Ther Med. 2021 Jan;21(1):3. doi: 10.3892/etm.2020.9435. Epub 2020 Nov 2.
8
Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review.2019年冠状病毒病(COVID-19)中医药注册临床试验的特征:一项范围综述。
Eur J Integr Med. 2021 Jan;41:101251. doi: 10.1016/j.eujim.2020.101251. Epub 2020 Nov 12.
9
Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.对抗新型冠状病毒的中草药化合物:葛根素和槲皮素可削弱病毒S蛋白与ACE2受体的结合。
Comput Struct Biotechnol J. 2020;18:3518-3527. doi: 10.1016/j.csbj.2020.11.010. Epub 2020 Nov 11.
10
Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.网络药理学、分子对接结合表面等离子共振技术揭示透解祛瘟颗粒治疗 2019 冠状病毒病肺炎的作用机制。
Phytomedicine. 2021 May;85:153401. doi: 10.1016/j.phymed.2020.153401. Epub 2020 Oct 28.